Trieza Therapeutics is Drug Discovery in United States that focus on Provider business. Founded in 2016. They cover business area such as Provider, cancer therapeutic, a portfolio, immuno-modulatory oncolytic virus, anti-tumor immune response, tumor-selective lysis, rapid, transient expression, engineer transgene, immuno-modulatory agent, patient, immune-stimulant, checkpoint inhibitor, ligand, coinhibitory receptor.
2016
( 8 years old in 2024 )
Provider
-
1030 Massachusetts Avenue
Suite 210
Cambridge, MA 02138
United States
Private
Providercancer therapeutica portfolioimmuno-modulatory oncolytic virusanti-tumor immune responsetumor-selective lysisrapid, transient expressionengineer transgeneimmuno-modulatory agentpatientimmune-stimulantcheckpoint inhibitorligandcoinhibitory receptor
* We use standard office opening hours in near Trieza Therapeutics's location as default value for unknown and outdated data. For more valid info, please verify the info from more trusted sources like GoogleMyBusiness, Yelp, FourSquare or similar services.
Trieza Therapeutics is Drug Discovery business from United States that founded in 2016 (8 years old in 2024), Trieza Therapeutics business is focusing on Provider.
Trieza Therapeutics headquarter office and corporate office address is located in 1030 Massachusetts Avenue Suite 210 Cambridge, MA 02138 United States.
Trieza Therapeutics was founded in United States.
In 2024, Trieza Therapeutics is currently focus on Provider sector.
Above is snippet of Google Trends for "Provider" term, if you have problem loading the snippet, please visit here: Google Trend.
Disclaimer: This website is not affiliated with Trieza Therapeutics, any government agency, does not create this data, vouch for its accuracy, or guarantee that it is the most recent data available. The data displayed is available through open government websites and public online directory. This website expressly disclaims the accuracy, adequacy, or completeness of any data and shall not be liable for any errors, omissions or other defects in, delays or interruptions in such data, or for any actions taken in reliance thereon.
